The Pacopexy procedure for left ventricular aneurysm: a 10-year clinical experience

  • Huimin Cui
  • Yuanbin Wu
  • Shixiong Wei
  • Changqing GaoEmail author
  • Shengli JiangEmail author
Original Article



To evaluate our 10-year clinical experience of performing the Pacopexy procedure for left ventricular aneurysm (LVA).


Between January, 1998 and November, 2015, a cohort of 92 patients with LVA underwent surgery to reshape the left ventricle. Fifty-seven patients underwent the Dor procedure and 35 underwent the Pacopexy procedure to emphasize the conical shape, whereby patch placement followed an oblique trajectory between the left ventricular apex and the septum below the aortic valve.


The early-mortality rate was 4.34% (4/92; n = 2 in each group). The 10-year survival rate was 70.4 ± 7.9% in the Pacopexy group vs 41.7 ± 7.2% in the Dor group (p < 0.05), and the rate of freedom from hospital re-admission for heart failure (HF) or cardiac death was 60.0 ± 8.6% vs 28.8 ± 6.8%, respectively (p < 0.05). The Dor procedure and left ventricular end systolic volume index (LVESVI) ≥ 60 ml/m2 were strongly and significantly associated with long-term mortality and hospital re-admission for HF.


The Pacopexy procedure is a reproducible surgical option for the treatment of LVA. The improved configuration achieved by the Pacopexy procedure has resulted in good long-term survival and a high degree of freedom from re-admission for HF in patients with advanced LVA.


Left ventricular aneurysm Surgical ventricular restoration Pacopexy 



  1. 1.
    Mills NL, Everson CT, Hockmuth DR. Technical advances in the treatment of left ventricular aneurysm. Ann Thorac Surg. 1993;55:792–800.CrossRefGoogle Scholar
  2. 2.
    Grondin P, Kretz JG, Bical O, Donzeau-Gouge P, Petitclerc R, Campeau L. Natural history of saccular aneurysms of the left ventricle. J Thorac Cardiovasc Surg. 1979;77:57–64.Google Scholar
  3. 3.
    Isomura T, Horii T, Suma H, Buckberg G. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not disease. Eur J Cardiothorac Surg. 2006;29S:S245–S250250.CrossRefGoogle Scholar
  4. 4.
    Di Donato M, Toso A, Maioli M, Sabatier M, Stanley AW Jr, Dor V, The Restore Group. Intermediate survival and predictors of death after surgical ventricular restoration. Semin Thorac Cardiovasc Surg. 2002;13(4):468–75.CrossRefGoogle Scholar
  5. 5.
    Buckberg GD, Coghlan HC, Torrent-Guasp F. The structure and function of the helical heart and its buttress wrapping. V. Anatomic and physiologic considerations in the healthy and failing heart. Semin Thorac Cardiovasc Surg. 2001;13(4):358–85.CrossRefGoogle Scholar
  6. 6.
    Torrent-Guasp F, Ballester M, Buckberg GD, Carreras F, Flotats A, Carrio I, Ferreira A, Samuels LE, Narula J. Spatial orientation of the ventricular muscle band: physiologic contribution and surgical implications. J Thorac Cardiovasc Surg. 2001;122(2):389–92.CrossRefGoogle Scholar
  7. 7.
    Buckberg GD, The RESTORE Group. Form versus disease: optimizing geometry during ventricular restoration. Eur J Cardio Thorac Surg. 2006;29S:S238–S244244.CrossRefGoogle Scholar
  8. 8.
    Castella M, Buckberg GD, Saleh S, Gharib M. Structure function interface with sequential shortening of basal and apical components of the myocardial band. Eur J Cardiothorac Surg. 2005;27(6):980–7.CrossRefGoogle Scholar
  9. 9.
    Buckberg GD, Clemente C, Cox JL, Coghlan HC, Castella M, Torrent-Guasp F, Gharib M. The structure and function of the helical heart and its buttress wrapping. IV. Concepts of dynamic function from the normal macroscopic helical structure. Semin Thorac Cardiovasc Surg. 2001;13(4):342–57.CrossRefGoogle Scholar
  10. 10.
    Sallin EA. Fiber orientation and ejection fraction in the human ventricle. Biophys J. 1969;9:954–64.CrossRefGoogle Scholar
  11. 11.
    Carabello BA, Spann JP. The uses and limitations of end-systolic indexes of left ventricular function. Circulation. 1984;69:1058.CrossRefGoogle Scholar
  12. 12.
    White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51.CrossRefGoogle Scholar
  13. 13.
    Migrino RQ, Young JB, Ellis SG, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 1997;96:116–21.CrossRefGoogle Scholar
  14. 14.
    Isomura T, Hoshino J, Fukada Y, Kitamura A, Katahira S, Kondo T, Iwasaki T, Buckberg G, The RESTORE Group. Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy. Eur J Heart Fail. 2011;13:423–31.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Cardiovascular SurgeryChinese PLA General HospitalBeijingChina

Personalised recommendations